Genetic polymorphisms of the human MDR1 drug transporter

被引:234
作者
Schwab, M
Eichelbaum, M
Fromm, MF
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
[2] Univ Tubingen Hosp, Div Clin Pharmacol, D-72076 Tubingen, Germany
关键词
P-glycoprotein; ABC transporter; pharmacogenetics; drug disposition; pharmacogenomics;
D O I
10.1146/annurev.pharmtox.43.100901.140233
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P-glycoprotein is an ATP-dependent efflux pump that contributes to the protection of the body from environmental toxins. It transports a huge variety of structurally diverse compounds. P-glycoprotein is involved in limiting absorption of xenobiotics from the gut lumen, in protection of sensitive tissues (brain, fetus, testis), and in biliary and urinary excretion of its substrates. P-glycoprotein can be inhibited or induced by xenobiotics, thereby contributing to variable drug disposition and drug interactions. Recently, several SNPs have been identified in the MDR1 gene, some of which can affect P-glycoprotein expression and function. Potential implications of MDR1 polymorphisms for drug disposition, drug effects, and disease risk are discussed.
引用
收藏
页码:285 / 307
页数:23
相关论文
共 110 条
[91]   Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and Caco-2 cell monolayers [J].
Soldner, A ;
Benet, LZ ;
Mutschler, E ;
Christians, U .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (06) :1235-1243
[92]   Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine [J].
Sparreboom, A ;
vanAsperen, J ;
Mayer, U ;
Schinkel, AH ;
Smit, JW ;
Meijer, DKF ;
Borst, P ;
Nooijen, WJ ;
Beijnen, JH ;
vanTellingen, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :2031-2035
[93]  
Stanulla M, 2001, BLOOD, V98, p317A
[94]   Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: role of canalicular multispecific organic anion transporter and P-glycoprotein [J].
Sugiyama, Y ;
Kato, Y ;
Chu, XY .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (Suppl 1) :S44-S49
[95]   Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine [J].
Suzuki, H ;
Sugiyama, Y .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (01) :3-12
[96]  
Tanabe M, 2001, J PHARMACOL EXP THER, V297, P1137
[97]   Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations [J].
Tang, K ;
Ngoi, SM ;
Gwee, PC ;
Chua, JMZ ;
Lee, EJD ;
Chong, SS ;
Lee, CGL .
PHARMACOGENETICS, 2002, 12 (06) :437-450
[98]   Inflammatory bowel disease - II. Gene mapping [J].
Taylor, KD ;
Yang, HY ;
Rotter, JI .
MOLECULAR GENETICS AND METABOLISM, 2001, 74 (1-2) :22-44
[99]  
TIRONA RG, 2002, PHARMACOGENOMICS SEA, P179
[100]  
UEDA K, 1992, J BIOL CHEM, V267, P24248